The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants
Open accessAbstract
A PAMless base editor: CRISPR-Cas DNA base editing typically requires a specific motif for targeting known as a protospacer-adjacent motif (PAM). This requirement limits the sequences within a genome that can be targeted. Walton et al. engineered specific variants of the Streptococcus pyogenes Cas9 enzyme named SpG and SpRY that could recognize and edit a wider array of PAMs. Using SpRY, the authors were able to correct previously uneditable mutations associated with human disease. Although off-target effects were observed for these engineered Cas enzymes at levels similar to those of the wild-type enzyme, depending on the context, these engineered enzymes widen the potential applications of precision genome editing. Science , this issue p. 290
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Efforts are ongoing to develop PAM-free Cas9 molecules to eliminate PAM site constraints altogether, thereby increasing the flexibility and effectiveness of genome editingthrough structure-based rational engineering or by altering amino acid substitutions in the PAM-interacting domain (Walton et al., 2020).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Walton et al., 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR-Cas dominates the field because of the ease of using guide RNAs directing the CRISPR complex to specific DNA sequences and the increasing ability to target most sites in the genome.121,122”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [122]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Building on this, Walton et al. (2020) introduced the SpG variant, which can recognize a broader range of NGN PAMs.”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Walton et al., 2020
The cited source says what the claim attributes to it.
In the citing paper
“These can be targeted in combination with evolved Cas9 variants such as SpCas9-NG20 or SpG.19”
From Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools (2024) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“These can be targeted with SpRY.19”
From Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools (2024) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“Cas9 genomic localization is delimited by the protospacer adjacent motif (PAM), which is NGG for SpCas9 while evolved variants of SpCas9 tolerate a broader range of PAM sequences17–21.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,761
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., & Joung, J. K. (2016) · Nature · doi:10.1038/nature16526 · Cited by 2,673
Self-citationRNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
Rationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
DNA interrogation by the CRISPR RNA-guided endonuclease Cas9
Sternberg, S. H., Redding, S., Jinek, M., Greene, E. C., & Doudna, J. A. (2014) · Nature · doi:10.1038/nature13011 · Cited by 1,822
Base editing: precision chemistry on the genome and transcriptome of living cells
Rees, H. A., & Liu, D. R. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0059-1 · Cited by 1,675
Flagged first, then by citations
1 of the 48 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 701–800 of 1,002
CRISPR-Cas technologies: Emerging tools from research to clinical application
Hyeon, H., Hwang, S., Luo, Y., Shin, E., Yeom, J., Kim, H., Ryu, M., & Lee, K. (2025) · The Journal of Microbiology · doi:10.71150/jm.2504012 · Cited by 7
Krausz, S. L., Simon, D. A., Bartos, Z., Biczók, Z., Varga, É., Huszár, K., Kulcsár, P. I., Tálas, A., Ligeti, Z., & Welker, E. (2025) · Nature Catalysis · doi:10.1038/s41929-025-01406-6 · Cited by 7
Gallo, D., Meunier, A., & Périn, C. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1663352 · Cited by 10
Reever, C. M., Boscia, A. R., Deutsch, T. C. J., Patel, M. P., Miralles, R. M., Kittur, S., Fleischel, E. J., Buo, A. M., Yorek, M. S., Meisler, M. H., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci196402 · Cited by 7
Therapeutic gene editing is here, can regulations keep up?
Kannan, S., & Najjar, D. (2020) · MIT Science Policy Review · doi:10.38105/spr.czm9c2w8ig · Cited by 7
O’Loughlin, S. M., Forster, A. J., Fuchs, S., Dottorini, T., Nolan, T., Crisanti, A., & Burt, A. (2021) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkab086 · Cited by 7
Umbach, A., Maule, G., Kheir, E., Cutarelli, A., Foglia, M., Guarrera, L., Fava, L. L., Conti, L., Garattini, E., Terao, M., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03135-0 · Cited by 7
Wada, N., Osakabe, K., & Osakabe, Y. (2022) · Gene and Genome Editing · doi:10.1016/j.ggedit.2022.100020 · Cited by 7
When push comes to shove - RNA polymerase and DNA-bound protein roadblocks
Hao, N., Donnelly, A. J., Dodd, I. B., & Shearwin, K. E. (2023) · Biophysical Reviews · doi:10.1007/s12551-023-01064-7 · Cited by 7
CRISPR-Cas9/Cas12a-based genome editing in Atlantic cod (Gadus morhua)
López‐Porras, A., Berg, R. S., Burgerhout, E., Hansen, Ø. J., Györkei, Á., Qiao, S., & Johansen, F. (2023) · Aquaculture · doi:10.1016/j.aquaculture.2023.740440 · Cited by 7
In vivo CRISPR base editing for treatment of Huntington’s disease
Shirguppe, S., Gapinske, M., Swami, D., Shenouda, K., Miskalis, A., Gosstola, N. C., Siller, D. D. B., Guerra, I., Acharya, P., Joulani, D., et al. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01747-y · Cited by 8
CRISPR-Cas System-Mediated Genetic Modification in Bacillus spp.: Current Status and Future
Wu, J., Zheng, S., Wang, L., Xia, X., Li, F., Lv, M.-L., Wu, Q., Huang, Z., & Miao, H. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c03140 · Cited by 7
Improving the specificity of nucleic acid detection with endonuclease-actuated degradation
Zou, R. S., Gavrilov, M. M., Liu, Y., Rasoloson, D., Conte, M., Hardick, J. P., Shen, L. L., Chen, S., Pekosz, A. S., Seydoux, G., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03242-x · Cited by 7
The use of base editing technology to characterize single nucleotide variants
McDaniel, S., Komor, A. C., & Goren, A. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.03.031 · Cited by 7
Silva, F. D. A., & Fontes, E. P. B. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.904829 · Cited by 7
Hassan, M. M., Yuan, G., Liu, Y., Alam, M. M., Eckert, C. A., Tuskan, G. A., Golz, J. F., & Yang, X. (2022) · Biotechnology Journal · doi:10.1002/biot.202100673 · Cited by 7
Highly efficient base editing in rabbit by using near-PAMless engineered CRISPR/Cas9 variants
Zhang, Z., Wu, X., Yang, J., Liu, X., Liu, R., & Song, Y. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2165-1 · Cited by 7
Hu, W., Yang, B., Xiao, Q., Wang, Y., Shuai, Y., Zhao, G., Zhang, L., Deng, Z., He, X., & Liu, G. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad743 · Cited by 7
Wang, X., Lv, P., Zhao, C., Yin, N., Fei, T., Shu, Y., & Wang, J. (2023) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2023.134666 · Cited by 7
Zhang, G., Song, Z., Huang, S., Wang, Y., Sun, J., Qiao, L., Li, G., Feng, Y., Han, W., Tang, J., et al. (2024) · Advanced Science · doi:10.1002/advs.202405426 · Cited by 7
Harnessing the power of directed evolution to improve genome editing systems
Su, Q., Zhou, M., Cheng, C., & Niu, J. (2021) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2021.02.004 · Cited by 8
Lb2Cas12a and its engineered variants mediate genome editing in human cells
Liu, X., Li, L., Tang, L., Xie, H., Gu, L., Lv, X., Liu, C., Zhao, J., Deng, R., Liu, Y., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202001013rr · Cited by 7
Lee, D., Lee, J. H., & Bang, D. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00056 · Cited by 7
Expanding the targeting scope of FokI‐dCas nuclease systems with SpRY and Mb2Cas12a
Cheng, Y., Sretenovic, S., Zhang, Y., Pan, C., Huang, J., & Qi, Y. (2022) · Biotechnology Journal · doi:10.1002/biot.202100571 · Cited by 7
Hänggeli, K. P. A., Hemphill, A. F., Müller, N., Schimanski, B., Olias, P., Müller, J., & Boubaker, G. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271011 · Cited by 7
Parallel engineering and activity profiling of a base editor system
Fong, J. H. C., Chu, H. Y., Zhou, P., & Wong, A. S. L. (2023) · Cell Systems · doi:10.1016/j.cels.2023.03.007 · Cited by 7
Functional rescue of F508del-CFTR through revertant mutations introduced by CRISPR base editing
Carrozzo, I., Maule, G., Gentile, C., Umbach, A., Ciciani, M., Guidone, D., Santis, M. D., Petris, G., Galietta, L. J. V., Arosio, D., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.01.011 · Cited by 6
Genome editing with programmable base editors in human cells
Osgood, N. R. B., Zawalick, N. M., Sawyer, C. B., Cowan, Q. T., Gu, S., Mawson, S. J., Ranzau, B. L., Li, L., Gymrek, M., Goren, A., et al. (2025) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2025.01.001 · Cited by 6
Advancements in Nonviral Gene Editing Strategies for Rare Diseases
Pérez-Maroto, J., Sepp‐Lorenzino, L., Castaño-Esteban, D., Palacios, D., & Sot, B. (2025) · Human Gene Therapy · doi:10.1177/10430342251372056 · Cited by 6
AI-guided Cas9 engineering provides an effective strategy to enhance base editing
Wei, D., Cheng, P., Song, Z., Liu, Y., Xu, X., Huang, X., Wang, X., Zhang, Y., Shu, W., & Wei, Y. (2025) · Molecular Systems Biology · doi:10.1038/s44320-025-00142-0 · Cited by 6
And… cut! – how conformational regulation of CRISPR-Cas effectors directs nuclease activity
Calvert, R. W., & Knott, G. J. (2025) · Biochemical Journal · doi:10.1042/bcj20240481 · Cited by 6
Guarding the genome: strategies for off-target detection and minimization in CRISPR/Cas9 system
Lotfi, M., Yazdi, Z. F., Hashemi, M. R., Abbaszadegan, M. R., & Sharif, S. (2025) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2025.2581677 · Cited by 6
Triple base editor catalyzes saturation mutation of adenine, cytidine, and guanine
Wu, Y., Wang, J., Zhang, Z., Shang, M., Wang, S. W., Li, Y., Li, G., lu, S., Ji, K., Wang, X., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1423 · Cited by 6
A primer on prime: A prime editing update from advances to first-in-human trial
Lushington, C., Thomas, P. Q., & Adikusuma, F. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.04.033 · Cited by 6
Lau, C., Huang, S., Lam, R. H. W., & Tin, C. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.05.005 · Cited by 6
Expanding the CRISPR/Cas genome-editing scope in Xenopus tropicalis
Shi, Z., Jiang, H., Liu, G., Shi, S., Zhang, X., & Chen, Y. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00841-3 · Cited by 6
Xiong, Y., Xi, X., Xiang, Y., Li, S., Liu, H., Su, Y., He, R., Xiong, C., Xu, B., Wang, X., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713331 · Cited by 6
Bhattacharya, S., Agarwal, A., & Muniyappa, K. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168550 · Cited by 6
Yao, Y., Zhou, Z., Wang, X., Liu, Z., Zhai, Y., Chi, X., Du, J., Luo, L., Zhao, Z., Wang, X., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100583 · Cited by 6
Steiner, S., & Roy, C. R. (2024) · mSphere · doi:10.1128/msphere.00523-24 · Cited by 6
Sokirniy, I., Inam, H., Tomaszkiewicz, M., Reynolds, J., McCandlish, D. M., & Pritchard, J. R. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf738 · Cited by 6
Cell-free screening of CRISPR-Cas activity by microfluidics-assisted in vitro compartmentalization
Bouzetos, E., Ganar, K. A., John van der, O. O. S. T., & Deshpande, S. (2025) · Trends in biotechnology · doi:10.1016/j.tibtech.2025.07.007 · Cited by 6
Narushima, J., Kimata, S., Shiwa, Y., Gondo, T., Akimoto, S., Soga, K., Yoshiba, S., Nakamura, K., Shibata, N., & Kondo, K. (2022) · Genes to Cells · doi:10.1111/gtc.12985 · Cited by 7
Enabling Precision Medicine with CRISPR-Cas Genome Editing Technology: A Translational Perspective
Ilahibaks, N. F., Hulsbos, M. J., Lei, Z., Vader, P., & Sluijter, J. P. G. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-5642-3_20 · Cited by 7
Prime Editing in Mammals: The Next Generation of Precision Genome Editing
Wang, D., Fan, X., Li, M., Liu, T., Lü, P., Wang, G., Li, Y., Han, J., & Zhao, J. (2022) · The CRISPR Journal · doi:10.1089/crispr.2022.0084 · Cited by 6
Benati, D., Leung, A., Perdigão, P. R. L., Toulis, V., van der Spuy, J., & Recchia, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315276 · Cited by 7
Watts, J. K. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781837671328-00350 · Cited by 6
Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy
Stampone, E., Bencivenga, D., Capellupo, M. C., Roberti, D., Tartaglione, I., Perrotta, S., Ragione, F. D., & Borriello, A. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04852-2 · Cited by 6
Plant Functional Genomics Based on High‐Throughput CRISPR Library Knockout Screening: A Perspective
He, J., Zeng, C., & Li, M. (2023) · Advanced Genetics · doi:10.1002/ggn2.202300203 · Cited by 6
Gene and epigenetic editing in the treatment of primary ciliopathies
Molinari, E., & Sayer, J. A. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.027 · Cited by 6
Wilson, J., & Loizou, J. I. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13272 · Cited by 6
Versatile and efficient genome editing with Neisseria cinerea Cas9
Liu, Z., Chen, S., Xie, W., Yu, H., Lai, L., & Li, Z. (2022) · Communications Biology · doi:10.1038/s42003-022-04258-z · Cited by 7
Dual guide RNA-mediated concurrent C&G-to-T&A and A&T-to-G&C conversions using CRISPR base editors
Zhao, Y., Li, M., Liu, J., Xue, X., Zhong, J., Lin, J., Ye, B., Chen, J., & Qiao, Y. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.12.055 · Cited by 6
Du, S. W., & Palczewski, K. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20230146 · Cited by 6
Targeted genome editing in grape using multiple CRISPR-guided editing systemsPreprint
Ren, C., Lin, Y., Li, H., Li, S., & Liang, Z. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.22.504768 · Cited by 6
Sensitive Transcriptomics and Genotyping reveals function of genetic variants in immunityPreprint
Liu, K., Rasmussen, A. W., Han, W., Gong, Q., Bohley, S., Chen, X. D., Kanai, M., Maronick, R., Yin, Z., Hu, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.12.642879 · Cited by 6
Tafech, B., Carlaw, T., Sadhnani, G., Schmidt, K., Morin, T., Leung, J., Weiner, J. M., An, K., Balázs, A., Ross, C. J., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114053 · Cited by 6
Induced Pluripotent Stem Cell-Based Cancer Immunotherapy: Strategies and Perspectives
Xun, X., Hao, J., Cheng, Q., & Gao, P. (2025) · Biomedicines · doi:10.3390/biomedicines13082012 · Cited by 5
From IscB to Cas9: Engineering and advances in the next generation of miniature gene editing tools
Zhou, C., Zhu, S., Luo, C., Wang, W., Fan, H.-Q., Gao, Y., Xu, X., Wang, Q., Yu, Y., & Xie, T. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108743 · Cited by 5
Ye, J., Liu, A., Lv, H., Sun, C., Wang, F., Zhang, H., & Zhang, H. (2025) · JACS Au · doi:10.1021/jacsau.5c00676 · Cited by 5
Metabolite-responsive scaffold RNAs for dynamic CRISPR transcriptional regulation
Stohr, A. M., Hansen, H., Richards, B., Park, H., Goncalves, A. G., Agrawal, A., Blenner, M., & Chen, W. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1290 · Cited by 5
Zhang, Z., Tao, Z., Zhang, W., Zhang, Z., Zhang, X., Xu, X., Yang, B., Meng, Y., Tao, X., & Zhou, X. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01591-1 · Cited by 6
From Lab to Field: CRISPRing Major Cultivated Solanaceae for Crop Improvement
Martina, F., Acquadro, A., & Moglia, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052238 · Cited by 5
Jan, F., Rathore, M., Saini, D. K., Singh, A., Qureshi, N., Aggarwal, N., Bashir, M., Shakeel, M., Gupta, V., Kumar, S., et al. (2026) · The Plant Genome · doi:10.1002/tpg2.70174 · Cited by 5
Wei, J., Brophy, B., Cole, S., Moormann, J., Boch, J., & Laible, G. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.925913 · Cited by 5
Strengthening microbial cell factories for efficient production of bioactive molecules
Singh, B., Kumar, A., Saini, A. K., Saini, R. V., Thakur, R., Mohammed, S. A., Tuli, H. S., Gupta, V. K., Areeshi, M. Y., Faidah, H. S., et al. (2023) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2023.2177039 · Cited by 5
Papaioannou, N. Y., Patsali, P., Naiisseh, B., Papasavva, P. L., Koniali, L., Kurita, R., Nakamura, Y., Christou, S., Sitarou, M., Mussolino, C., et al. (2023) · Frontiers in Genome Editing · doi:10.3389/fgeed.2023.1141618 · Cited by 5
Genome engineering in bacteria: Current and prospective applications
(2023) · Methods in microbiology · doi:10.1016/bs.mim.2023.01.003 · Cited by 5
Efficient genome editing using modified Cas9 proteins in zebrafish
Dorner, L., Stratmann, B., Bader, L., Podobnik, M., & Irion, U. (2024) · Biology Open · doi:10.1242/bio.060401 · Cited by 7
Calbry, J., Goudounet, G., Charlot, F., Guyon‐Debast, A., Perroud, P., & Nogué, F. (2024) · Transgenic Research · doi:10.1007/s11248-024-00381-1 · Cited by 5
Expanding the targeting scope of CRISPR/Cas9-mediated genome editing by Cas9 variants in Brassica
Li, W., Li, X., Wang, C., Huo, G., Zhang, X., Yu, J., Yu, X., Li, J., Zhang, C., Zhao, J., et al. (2024) · aBIOTECH · doi:10.1007/s42994-024-00155-7 · Cited by 5
Loret, C., Pauset, A., Faye, P.-A., Prouzet‐Mauleon, V., Pyromali, I., Nizou, A., Miressi, F., Sturtz, F. G., Favreau, F. D., Turcq, B., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12071550 · Cited by 5
Lü, D., Gong, X., Guo, X., Qin, C., Chen, Y., Zhu, Y., Sang, X. M., Yang, H., Xu, M., Zeng, Y., et al. (2024) · Human Gene Therapy · doi:10.1089/hum.2023.202 · Cited by 6
Advancing CRISPR base editing technology through innovative strategies and ideas
Fan, X., Lei, Y., Wang, L., Wu, X., & Li, D. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2699-5 · Cited by 5
Tan, W. Z., Wang, Z., & Liu, L. (2024) · Agriculture · doi:10.3390/agriculture15010029 · Cited by 5
Omura, S. N., & Nureki, O. (2025) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2025.01.052 · Cited by 5
Editor’s Choice Protein engineering strategies to develop lectins by design
Hombu, R., Beatty, L. E., & Neelamegham, S. (2025) · Glycobiology · doi:10.1093/glycob/cwaf041 · Cited by 5
Gupta, D., Patinios, C., Bassett, H. V., Kibe, A., Collins, S. P., Kamm, C., Wang, Y., Zhao, C., Vollen, K., Toussaint, C., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02802-w · Cited by 5
Sharma, S., Ali, R., Bouska, A. C., Jochum, D. T., Kesireddy, M., Mahov, S., Lownik, J. C., Zhang, W., Lone, W., Soma, M. A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64666-7 · Cited by 5
The potential of CRISPR-Cas9 prime editing for cardiovascular disease research and therapy
Bharucha, N., Arias, A., & Karakikes, I. (2022) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000985 · Cited by 5
Gene Editing Corrects In Vitro a G > A GLB1 Transition from a GM1 Gangliosidosis Patient
Leclerc, D., Goujon, L., Jaillard, S., Nouyou, B., Cluzeau, L., Damaj, L., Dubourg, C., Etcheverry, A., Levade, T., Froissart, R., et al. (2023) · The CRISPR Journal · doi:10.1089/crispr.2022.0045 · Cited by 5
YIPF5 (p.W218R) mutation induced primary microcephaly in rabbits
Liu, X. Z., Yang, J., Li, Z., Liu, R., Wu, X., Zhang, Z., Lai, L., Li, Z., & Song, Y. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106135 · Cited by 5
Ishikawa, K., Soejima, S., & Saitoh, S. (2023) · Journal of Cell Science · doi:10.1242/jcs.261186 · Cited by 6
Protein engineering technologies for development of next-generation genome editors
Winter, J., Shirguppe, S., & Pérez‐Piñera, P. (2023) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2023.100514 · Cited by 5
The Development and Application of a Base Editor in Biomedicine
Wang, F., Zeng, Y., Wang, Y., & Niu, Y. (2020) · BioMed Research International · doi:10.1155/2020/2907623 · Cited by 5
Repurposing CRISPR-Cas Systems as Genetic Tools for the Enterobacteriales
Backes, N., & Phillips, G. J. (2021) · EcoSal Plus · doi:10.1128/ecosalplus.esp-0006-2020 · Cited by 5
Wu, S., Li, L., Li, M., Sun, S., Zhao, Y., Xue, X., Chen, F., Zhong, J., Guo, J., Qu, Q., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.809922 · Cited by 5
Building Blocks of Artificial CRISPR-Based Systems beyond Nucleases
Kuzmin, A. A., & Tomilin, A. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010397 · Cited by 5
Xiong, X., Lu, Z., Ma, L., & Zhai, C. (2023) · Biomolecules · doi:10.3390/biom13071022 · Cited by 5
Kansal, R. (2020) · Journal of Clinical Haematology · doi:10.33696/haematology.1.006 · Cited by 5
Potential CRISPR Base Editing Therapeutic Options in a Sorsby Fundus Dystrophy Patient
Elsayed, M. E. A. A., Kaukonen, M. K., Kiraly, P., Cehajic‐Kapetanovic, J., & MacLaren, R. E. (2022) · Genes · doi:10.3390/genes13112103 · Cited by 6
McGrail, M. A., Sakuma, T., & Bleris, L. G. (2022) · Scientific Reports · doi:10.1038/s41598-022-24850-x · Cited by 5
Lang, S., Lin, X., Wang, S., Sun, W., Yang, Y., Chen, Y., Bao, Z., Feng, W., Wang, Y., & Luo, Y. (2025) · Environment & Health · doi:10.1021/envhealth.5c00072 · Cited by 4
Prime editing using paired pegRNAs targeting NG- or NGG-PAM in rice
Nishizawa‐Yokoi, A., Iida, K., Mori, A., & Toki, S. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1550308 · Cited by 4
Flexibility in PAM recognition expands DNA targeting in xCas9
Hossain, K. A., Nierzwicki, Ł., Orozco, M., Czub, J., & Palermo, G. (2025) · eLife · doi:10.7554/elife.102538.3 · Cited by 4
Energetics of Expanded PAM Readability by Engineered Cas9-NG
Bhattacharya, S., & Satpati, P. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00011 · Cited by 4
Shon, Y. J., Baek, D., Jin, S., Kim, W. J., Jung, G. Y., & Lim, H. G. (2025) · Journal of Biological Engineering · doi:10.1186/s13036-025-00500-4 · Cited by 4
Directed Evolution of OgeuIscB With Enhanced Activity in Human Cells
Lv, J., Jin, J., Ding, L., Xiang, L., Xie, B., Wu, K., & Chen, Q. (2025) · The FASEB Journal · doi:10.1096/fj.202500082r · Cited by 4
BEscreen: a versatile toolkit to design base editing libraries
Schneider, P. G., Liu, S., Bullinger, L., & Ostendorf, B. N. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf406 · Cited by 4
Optimizing gene editing in pigs: The role of electroporation and lipofection
Piñeiro-Silva, C., & Gadea, J. (2025) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2025.107874 · Cited by 4
Metadata
- Authors
- Walton, R. T., Christie, K. A., Whittaker, M. N., & Kleinstiver, B. P.
- Affiliations
- Massachusetts General Hospital (US)
- Harvard University (US)
- Corresponding author
- Kleinstiver, Benjamin P.
- Venue
- Science
- Published
- 2020-04-17
- Volume
- 368
- Issue
- 6488
- Pages
- 290-296
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7297043
- OpenAlex
- W3013504322
- Semantic Scholar
- 84609b61a82a11e3122a81b5bdae20a2822e577b
- Cited by
- 1,233
- References
- 48
- Citations by year
- 2026: 157 · 2025: 200 · 2024: 190 · 2023: 213 · 2022: 203 · 2021: 177 · 2020: 93
- FWCI
- 56.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01-HL142494)
- National Cancer Institute (R00-CA218870)
- American Society of Gene and Cell Therapy
- Margaret Q. Landenberger Research Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Keywords
- CRISPR/Cas9, SpCas9, SPG, SpRY, base editing, genome editing, human cells
- MeSH terms
- Protein Domains, Gene Editing, CRISPR-Associated Protein 9, Humans, Substrate Specificity, Mutagenesis, Gene Targeting, Genetic Predisposition to Disease, HEK293 Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review